Neurological complications of coronary angiographic procedures

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 6, 2007, Pages 1113-1121

  Duffis, Ennis J ^a   Jones, David ^a   Tighe, Dennis ^b   Moonis, Majaz ^b  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Complications; Contrast reaction; Coronary catheterization; Stroke; Transient cortical blindness

Indexed keywords

IOPAMIDOL;

ADULT; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DIPLOPIA; FLUOROSCOPY; HEADACHE; HEART CATHETERIZATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROLOGIC DISEASE; NYSTAGMUS; REVIEW; VERTIGO; VISUAL DISORDER;

ADULT; AGED; BRAIN ISCHEMIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RISK ASSESSMENT; STROKE; SURVIVAL ANALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 37349024319     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.6.1113     Document Type: Review

References (49)

1. National Center for Health Statistics. 1999 National hosptal Discharge Survey, Annual Summary with detailed diagnosis and procedur data. US Dept. of Health and Human Services, DC, USA 151 (2001).
2. Lazar JM, Uretsky BE DenysBG, Reddy PS, Counihan PJ, Ragosta M. Predisposing risk factors and natural history of acute neurological complication of left-sided cardiac catheterization. Am. J. Cardiol. 75, 056-1060 (1995).
3. Busing, KA, Schulte-Sasse C, Fluchter S et al. Cerebral infarction, Incindence and risk factor's after diagnostic interventional cardiac catheterization-prospective evaluation at diffusion weighted MR imaging. Neuroradiology 235,177-183 (2005).
4. Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Ann. Neurol. 13, 469-484 (1983).
5. Liu XY, Wong V, Leung M. Neurological complications due to catheterization. Pediatr. Neurol. 24, 270-275 (2001).
6. Weissman B, Aram DM, Levinsohn WM et al. Neurological sequelae of cardiac catheterization. Cathet. Cardiovasc. Diagn. 11, 577-583 (1985).
7. Gellen B, Remp T, Mayer T, Milz P, Franz WM. Cortical blindness: a rare but dramatic complication following coronary angiography. Cardiology 99 57-59 (2003).
8. Henzlova MJ, Coghlan HC, Dean LS, Taylor JL. Cortical blindness after left internal mammary artery to left anterior descending coronary artery graft angiography, Cathet. Cardiovasc. Diagn. 15, 37-39 (1988).
9. Sticherling C, Berkefeld J, Auch-Schwelk W, Lanfermann H. Transient bilateral cortical blindness after coronary angiography (letter). Lancet 351, 570 (1998).
10. Antonellis J, Kostopoulos K, Rambaouni A et al. Cortical blindness following coronary arteriography: a rare but self-cured complication. Angiology 47, 803-806 (1996).
11. Kinn RM, Breisblatt WM. Cortical blindness after coronary angiography: a rare but reversible condition. Cathet. Cardiovasc. Diagn. 22, 177-179 (1991).
12. Parry R, Rees JR, Wilde P. Transient cortical blindness after coronary angiography. Br. Heart J. 70, 563-564 (1993).
13. Kwok BWK, Lim TT. Cortical blindness following coronary angiography. Singapore Med. J. 41, 604-605 (2000).
14. Zwicker JC, Sila CA. MRI findings in a case of transient cortical blindness after cardiac catheterization, Cathet. Cardiovasc. Diagn. 57, 47-49 (2002).
15. Rama BN, Pagano TV, DelCore M, Knobei KR, Lee J. Cortical blindness after cardiac catheterization: effect of rechallenge with dye. Cathet. Cardiovasc. Diagn. 28, 149-151 (1993).
16. Lantos G. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material, CT and MRI studies. Neurology 39, 567-571 (1989).
17. Kermode AG, Chakera T, Mastaglia FL. Low-osmolar and non-ionic x-ray contrast media and cortical blindness. Clin, Exp. Neurol. 29, 272-276 (1992).
18. Tamaki K, Sadoshima S, Heistad DD. Increased susceptibility to osmotic dirsruption of the blood-brain barrier in chronic hypertension. Hypertension 6, 633-638 (1984).
19. Cottesman RE Sherman PM, Grega MA et al. Watershed stroke after cardiac surgery: diagnosis, etiology, and outcome. Stroke 37, 2306-2311 (2006).
20. Khatri P, Kasner SE. Ischemic strokes after cardiac catheterization, opportune thrombolysis candidates. Arch. Neurol. 63, 817-821 (2006).
21. Dukkipati S, O'Neill WW, Harjai KJ et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am. Coll. Cardiol. 43, 1161-1167 (2004).
22. Fuchs S, Stabile E, Kinnaird TD et al. Stroke complicating percutaneous coronary interventions, incidence, predictors, and prognostic implications. Circulation 106, 86-91 (2002).
23. Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rodford G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology 56, 975-977 (2001).
24. Omran H, Schmid H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterization of the aortic valve in valvular stenosis, a prospective, randomised study. Lancet 361, 1241-1246 (2003).
25. Lund C, Nes RB, Ugelstad TP et al. Cerebral emboli during left heart catherization may cause acute brain injury. Eur. Heart J. 26, 1269-1275 (2005).
26. Kosmorsky, G Hanson S, Tornsak R. Neuro-ophthalmologic complications of cardiac catheterization. Neurology 38, 483-485 (1988).
27. Hamon M, Gomes S, Oppenheim C et al. Cerebral microembolism during cardiac catheterization and risk of acute brain injury. Stroke 37, 2035-2038 (2006).
28. Fisher A, Ozbek C, Bay W, Hamann GF. Cerebral microemboli during left heart catheterization, Am. Heart J. 137, 162-168 (1999).
29. Stygall J, Kong R, Walker JM et al. Cerebral microembolism detected by Transcranial Doppler during cardiac procedures. Stroke 31, 2508-2510 (2000).
30. Qureshi AI, Luft AR, Sharma M et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures, part 1, pathophysiological. and pharmacological features. Neurosurgery 46, 1344-1359 (2000).
31. Bladin CF, Bingham L, Grigg L et al. Transcranial Doppler detection of microemboll during percutaneous transluminal. coronary angioplasty. Stroke 29, 2367-2370 (1998).
32. Piessens JH, Stammen F, Vrolix MC et al. Effects of an ionic versus an nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cath. Candiovasr. Diagn. 28, 99-105 (1993).
33. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters. J. Am. Coll. Cardiol. 23, 1862-1865 (1998).
34. Akkerhuis KM, Deckers JW, Lincoff AM et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervenion. JAMA 286, 78-82 (2001).
35. Mahaffey KW, Granger CB, Sloan MA et al. Risk factors for in-hospital non-hemorrhagic stroke in patients with acue myocardial infarction treated with thrombolysis, resultsfor GUSTO-I. Circulation 97, 757-764. (1998).
36. Collins R, MacMahon S, Flather M et al. Clinical effects of anticoagulation therapy in suspected acute myocardial infarction, systematic overview of randomized trials. BMJ 313, 652-659 (1996).
37. Brenner SJ, Moliterno DJ, Lincoff AM et al. Relationship between activated clotting time and ischemic or hemorrhagic complications analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation 110, 994-998 (2004).
38. Keilson GR, Schwartz WJ, Recht LD. The preponderance of posterior circulatory events is independent of the route of cardiac catheterization. Stroke 23, 1358-1359 (1992).
39. Dawson DM, Fischer EG. Neurological complications of cardiac catheterization. Neurology 27, 496-497 (1977).
40. Leclercq F, Kassnasrallah S, Cesari JB et al. Transcranial Doppler detection of cerebral microemboli during left heart catheterization. Cerebrovasc. Dis. 12, 59-65 (2001).
41. Brown DL, Topol J. Stroke complicating percutaneous coronary revascularization. Am. J. Cardiol. 72, 1207-1209 (1993).
42. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587 (1995).
43. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276g), results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 31, 811-816 (2000).
44. Del Zoppo GJ, Higashida R, Furlan A et al. PROACT, a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery occlusion. Stroke 35, 705-709 (2004).
45. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute arterial ischemic stroke, The PROACT-II Study: a randomized control trial, Prolyse in acute cerebral thromboembolism. JAMA 282, 2003-2011 (1999).
46. Zaidat OO, Slivka AP Mohammad Y et al. Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. Stroke 36, 1089-1090 (2005).
47. Al-Mubarak N, Vitek JJ, Mousa I et al. Immediate catheter based neurovascular rescue for acute stroke complicating coronary procedures. Am. J Cardiol. 90, 173-176 (2002).
48. Sandoval AE, Laufer N. Thromboembolic stroke complicating coronary intervention, acute evaluation and management in the cardiac catheterization laboratory. Cathet. Cardiovasc. Diagn. 44, 412-414 (1998).
49. Chan AW, Henderson MA. Immediate catheter-directed reperfusion for acute stroke occurring during diagnostic cardiac catheterization. Catheter. Cardiovasc. Interv. 67, 314-318 (2006).